Revenue from Startup Bonuses
Sponsors are keen to get drugs to market as early in their patent-window as possible and days of study acceleration can mean millions in additional revenue for a given therapy. As an incentive to speed studies, sponsors are offering sites startup bonuses – payments received for hitting specified startup metrics such as site initiation and time to first patient.
$2,000 average per study bonus
Sponsors are offering startup bonuses exceeding $10,000 per protocol per site (Florence Healthcare Analysis, 2017).
eBinder platforms can help sites meet sponsors’ needs by reducing task time and accelerating the overall startup phase. Centers can capture more startup bonuses as a result.
Net: We estimate one in five studies can reliably deliver this bonus, so on average startup bonuses yield $2,000 per industry- sponsored oncology study.
The ROI of an eRegulatory Platform
www.FlorenceHC.com © Florence Healthcare
Page 7 of 14
Made with FlippingBook Digital Proposal Creator